- Home
- QURE vs VMO Comparison
QURE vs VMO Comparison
Compare QURE & VMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- VMO
- Stock Information
- Founded
- QURE 1998
- VMO 1992
- Country
- QURE Netherlands
- VMO United States
- Employees
- QURE N/A
- VMO N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- VMO Trusts Except Educational Religious and Charitable
- Sector
- QURE Health Care
- VMO Finance
- Exchange
- QURE Nasdaq
- VMO Nasdaq
- Market Cap
- QURE 725.4M
- VMO 612.4M
- IPO Year
- QURE 2007
- VMO N/A
- Fundamental
- Price
- QURE $17.27
- VMO $9.04
- Analyst Decision
- QURE Strong Buy
- VMO
- Analyst Count
- QURE 10
- VMO 0
- Target Price
- QURE $37.20
- VMO N/A
- AVG Volume (30 Days)
- QURE 1.4M
- VMO 254.7K
- Earning Date
- QURE 07-31-2025
- VMO 01-01-0001
- Dividend Yield
- QURE N/A
- VMO 4.39%
- EPS Growth
- QURE N/A
- VMO N/A
- EPS
- QURE N/A
- VMO N/A
- Revenue
- QURE $20,201,000.00
- VMO N/A
- Revenue This Year
- QURE $27.16
- VMO N/A
- Revenue Next Year
- QURE $248.21
- VMO N/A
- P/E Ratio
- QURE N/A
- VMO N/A
- Revenue Growth
- QURE 6.30
- VMO N/A
- 52 Week Low
- QURE $3.73
- VMO $7.86
- 52 Week High
- QURE $19.18
- VMO $9.87
- Technical
- Relative Strength Index (RSI)
- QURE 67.53
- VMO 35.20
- Support Level
- QURE $14.75
- VMO $9.05
- Resistance Level
- QURE $15.50
- VMO $9.19
- Average True Range (ATR)
- QURE 1.07
- VMO 0.07
- MACD
- QURE 0.16
- VMO -0.01
- Stochastic Oscillator
- QURE 93.40
- VMO 2.08
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About VMO Invesco Municipal Opportunity Trust
Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.